An Enhanced Treatment Algorithm Targeting Mucosal Healing is Effective and Safe in Older Patients with Crohn&apos;s Disease: A Post-hoc Analysis of the REACT2 Trial

Inflammatory Bowel Disease

Corticosteroid-sparing effects of risankizumab versus ustekinumab in patients with moderately to severely active Crohn's disease: post hoc results from the phase 3b SEQUENCE trial

J Crohns Colitis

Raine T, Danese S, Schreiber S, Gao X, Hanauer S, Torres J, Cunneen C, Kligys K, Huang X, Garrison A, Neimark E, Anschutz T, Crowley J, Cross RK

doi: 10.1093/ecco-jcc/jjag104

Inflammatory Bowel Disease

Comparative Efficacy and Safety of Advanced Therapies in Maintenance Treatment of Adult Patients with Moderate-to-Severe Crohn's Disease: A Systematic Literature Review and Network Meta-Analysis

Adv Ther

Schreiber S, Danese S, Colombel JF, Hisamatsu T, Irving PM, Park H, Kim DH, Lee YN, Hanauer SB

doi: 10.1007/s12325-025-03447-6

Inflammatory Bowel Disease

Patients with Crohn's disease achieving transmural healing experience superior long-term outcomes compared with those with endoscopic or radiologic healing alone

Inflamm Bowel Dis

Vuyyuru SK, Goodwin SW, Solitano V, Ramsewak D, Kassam Z, Townsend C, Gregor J, Beaton M, Crowley E, Alkhattabi M, Sey M, Jairath V

doi: 10.1093/ibd/izag114

Inflammatory Bowel Disease

Integrating Intestinal Ultrasound to Clinical Trials in Patients With Crohn's Disease: Opportunities and Challenges

Inflamm Bowel Dis

Jairath V, Adsul S, Allocca M, Danese S, Dubinsky MC, de Oliveira MF, Ma C, Kucharzik T, Novak KL, Panaccione R, Bautista IR, Sands BE, Taylor SA, Wilkens R, Maaser C

doi: 10.1093/ibd/izaf196

Inflammatory Bowel Disease

Comparative Study on the Management and Outcomes of Postoperative Crohn's Disease in Older Patients: Data From the ENEIDA Registry

United European Gastroenterol J

Mañosa M, Calafat M, Ricart E, Nos P, Iglesias E, Riestra S, Mesonero F, Calvo M, Guardiola J, Hernández V, Rivero M, Carpio D, Mínguez M, Alba C, Martín-Arranz MD, Vela M, Gomollón F, García-López S, Casbas AG, Calvet X, González-Muñoza C, Barrio J, Gisbert JP, Sicilia B, Pérez-Calle JL, Bujanda L, Esteve M, Ramos L, Varela P, Sierra M, Merino O, Bermejo F, Acosta MB, Perez AR, Márquez-Mosquera L, García-Bosch O, Rodríguez-Lago I, Lorente Poyatos RH, García Sepulcre MF, Maroto N, Vega P, Monfort D, San Martín LZ, Busquets D, Martinez-Montiel P, Riera J, Alcain G, Llaó J, Marin N, Marin-Jimenez I, Sesé E, Van Domselaar M, Huguet JM, Ginard D, Bas-Cutrina F, Ber Y, Roncero O, Lucendo AJ, López-García A, Menacho M, Almela P, Ponferrada Á, Coronel AF, Maestro S, de Jesús Martínez-Pérez T, Vilafranca CM, Argüelles F, Legido J, Gilabert P, Charro M, Trapero AM, Fernández H, Frago S, Villalba LH, Muñoz E, Domènech E, ENEIDA registry of GETECCU

doi: 10.1002/ueg2.70150

Inflammatory Bowel Disease

Magnetic resonance imaging-based simplified MaRIA scores are associated with future surgery in Crohn's disease, but modest correlation with ileo-colonoscopic inflammation limits their utility in clinical trials: results from the PROFILE trial

J Crohns Colitis

Bhandari M, Sharip MT, Noor NM, Khwaja S, Paverd H, De Paepe KN, Godfrey E, Hickman K, Patel KV, Subramanian S, Raine T, Lee JC, Kennedy NA, Upponi S, Parkes M, PROFILE Study Group

doi: 10.1093/ecco-jcc/jjag056

Inflammatory Bowel Disease

Efficacy and safety of duvakitug in patients with Crohn's disease (RELIEVE UCCD): a phase 2b, randomised, placebo-controlled trial

Lancet Gastroenterol Hepatol

Jairath V, Kierkuś J, Duvall GA, Danese S, Sands BE, Ratiu-Duma B, Singh R, Levine P, Barkay H, Gross N, Abrams K, Reinisch W

doi: 10.1016/S2468-1253(26)00119-6

Inflammatory Bowel Disease

Mirikizumab Long-Term Efficacy and Safety in Patients with Crohn's disease: Results from the VIVID-2 Open-Label Extension Trial

Clin Gastroenterol Hepatol

Sands BE, Barnes EL, D'Haens G, Hisamatsu T, Regueiro M, Kelly CR, Laharie D, Hozak RR, Yu G, Gandhi R A, Lopes MU, Durand F, Protic M, Moses RE, Vermeire S

doi: 10.1016/j.cgh.2026.01.049

Inflammatory Bowel Disease

Prognostic Significance of Different Endoscopic Scores in Post-Operative Crohn's Disease and their Role in Patients with Low-Risk Features

Adv Ther

Del Gaudio A, Parisio L, Privitera G, Cuccia G, Coppola G, Laterza L, Lopetuso LR, Gasbarrini A, Carbone L, Papa A, Scaldaferri F, Pugliese D

doi: 10.1007/s12325-025-03466-3

Gastroenterology

An Enhanced Treatment Algorithm Targeting Mucosal Healing is Effective and Safe in Older Patients with Crohn's Disease: A Post-hoc Analysis of the REACT2 Trial

Related content

Corticosteroid-sparing effects of risankizumab versus ustekinumab in patients with moderately to severely active Crohn's disease: post hoc results from the phase 3b SEQUENCE trial

Comparative Efficacy and Safety of Advanced Therapies in Maintenance Treatment of Adult Patients with Moderate-to-Severe Crohn's Disease: A Systematic Literature Review and Network Meta-Analysis

Patients with Crohn's disease achieving transmural healing experience superior long-term outcomes compared with those with endoscopic or radiologic healing alone

Integrating Intestinal Ultrasound to Clinical Trials in Patients With Crohn's Disease: Opportunities and Challenges

Comparative Study on the Management and Outcomes of Postoperative Crohn's Disease in Older Patients: Data From the ENEIDA Registry

Magnetic resonance imaging-based simplified MaRIA scores are associated with future surgery in Crohn's disease, but modest correlation with ileo-colonoscopic inflammation limits their utility in clinical trials: results from the PROFILE trial

Efficacy and safety of duvakitug in patients with Crohn's disease (RELIEVE UCCD): a phase 2b, randomised, placebo-controlled trial

Mirikizumab Long-Term Efficacy and Safety in Patients with Crohn's disease: Results from the VIVID-2 Open-Label Extension Trial

Prognostic Significance of Different Endoscopic Scores in Post-Operative Crohn's Disease and their Role in Patients with Low-Risk Features